abstract |
The present invention relates to stable crystal modifications of DOTAP chloride, in particular racemic (2R,S)‑ and enantiomerically pure (2R)‑ and (2S)‑, crystal modifications of DOTAP chloride, to Its preparation method, as well as its use for the preparation of pharmaceutical compositions. |